Riker Laboratories, Inc., a Corporation of Delaware v. Gist-Brocades N. v. a Corporation of the Netherlands

636 F.2d 772, 205 U.S. App. D.C. 64, 1980 U.S. App. LEXIS 11944
CourtCourt of Appeals for the D.C. Circuit
DecidedNovember 26, 1980
Docket78-2322
StatusPublished
Cited by17 cases

This text of 636 F.2d 772 (Riker Laboratories, Inc., a Corporation of Delaware v. Gist-Brocades N. v. a Corporation of the Netherlands) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Riker Laboratories, Inc., a Corporation of Delaware v. Gist-Brocades N. v. a Corporation of the Netherlands, 636 F.2d 772, 205 U.S. App. D.C. 64, 1980 U.S. App. LEXIS 11944 (D.C. Cir. 1980).

Opinion

Opinion for the Court filed by Circuit Judge MacKINNON.

MacKINNON, Circuit Judge.

The major issue in this appeal is whether 35 U.S.C. § 293 confers personal jurisdiction over a foreign patentee when allegations of patent misuse are made. We hold that the statute does, and reverse the determination of the district court dismissing the action for lack of personal jurisdiction. We also find that subject matter jurisdiction exists to support consideration of the antitrust claims and direct the district court, on remand, to determine whether its pendent jurisdiction should be exercised to consider the other claims presented in the complaint.

I

On July 4, 1961 Gist-Brocades N.V., a Netherlands Corporation (the defendant-appellee) was issued United States Patent No. 2,991,225 defined as “therapeutic compositions containing Orphenadrine Hydrochloride or Orphenadrine Citrate.” These compositions are used in the treatment of Parkinson’s Disease, obsession, depression and skeletal muscle disorders. (App. 4, Complaint ¶ 6). On December 17,1962 Gist-Brocades (“Brocades”) entered into an agreement licensing plaintiff-appellant RikerLaboratories (“Riker”), a wholly owned subsidiary of Minnesota Mining and Manufacturing Company, to make, use and sell the *774 patented compositions. While Gist-Brocades is a non-resident patentee it has not filed with the Patent Office a designation of an agent for service of process in the United States. As part of the licensing agreement, Riker was licensed to use Brocades’ DISIPAL trademark. Riker subsequently developed the trademarks NOR-FLEX and NORGESIC. All three trademarks were used by Riker in marketing medications containing Orphenadrine Hydrochloride or Orphenadrine Citrate.

By the terms of the licensing agreement, Riker was. required to use the DISIPAL trademark and to obtain, develop and hold in trust the NORFLEX and NORGESIC trademarks until the license agreement was terminated or the patent expired, at which time Riker was required to assign “all its right, title and interest in and to the trademarks in question” and “that part of the good will of the business connected with the use of and symbolized by such trademark or trademarks” in the United States. (App. 5, Complaint ¶ 10). This provision of the licensing agreement forms the basis for Rikers’ allegation that “Brocades, thus tied Riker to the use of trademarks that Brocades would own on compositions made under Brocades’ patent.” (App. 5 Complaint ¶ 10). Riker contends that this alleged patent misuse provides a basis for obtaining personal jurisdiction under 35 U.S.C. § 293 as a proceeding “affecting the patent or rights thereunder.”

From 1962 to 1974, the relationship between Riker and Brocades was untroubled. During that twelve-year period, Riker paid what it describes as “substantial royalties.” (App. 9 Complaint ¶.25). In early 1975, however, unlicensed competitors intruded into Riker’s sales. At a meeting held in May 1975 to map a strategy for dealing with infringers, Riker requested amendment of the licensing agreement to negate the article containing the trademark tie-in, and post-patent royalty provisions for continued use of the trademarks. Riker contended that these provisions were violative of the United States anti-trust laws, constituted patent misuse, and prevented enforcement of the patent against the infringers.

The May meeting, and several others, were unsuccessful in resolving the questions of unlicensed infringers or Riker’s request for amendment of the license. On September 15, 1976, Riker informed Brocades that the existence of substantial infringing competition would require a reduction in its royalty rate by one-half, as provided by the agreement. Brocades, in return, demanded proof of the extent of the infringement. Subsequently, on July 26, 1977, Riker repudiated the license agreement, stating the royalties would be paid as though a straight license agreement existed, at the continued reduced rate, because of the infringing competition. After another unsuccessful meeting, held in September 1977, Riker can-celled the agreement on January 10, 1978. Riker identified the anti-trust questions involving the trademarks as the basis for the cancellation and advised Brocades that no further royalty payments would be made.

On March 28, 1978, Riker instituted this action requesting declaratory, injunctive, and monetary relief. On October 23, 1978, the district court dismissed the action without prejudice stating that “it appear[s] under the law of this Circuit personal jurisdiction on the basis of 35 U.S.C. § 293 is validly asserted against a foreign patentee only if the patent claim is one of infringement or invalidity, Neidhart v. Neidhart S.A., 510 F.2d 760 (D.C.Cir.1975), ...”. An appeal was taken on October 19, 1978.

In the interim the patent expired on July 4, 1978.

II

The starting point for our determination whether 35 U.S.C. § 293 provides a jurisdictional basis for Riker’s action against Brocades in the United States is the provision of the statute:

Every patentee not residing in the United States may file in the Patent Office a written designation stating the name and address of a person residing within the United States on whom may be served process or notice of proceedings affecting the patent or rights thereunder. *775 If the person designated cannot be found at the address given in the last designation, or if no person has been designated, the United States District Court for the District of Columbia shall have jurisdiction and summons shall be served by publication or otherwise as the court directs. The court shall have the same jurisdiction to take any action respecting the patent or rights thereunder that it would have if the patentee were personally within the jurisdiction of the court. (Emphasis added).

This section is, by its terms, a long arm statute; a non-resident patentee is presented with the option of designating an agent for service of process or of receiving notice by publication or other means, such as the mail service used in this ease. In either event, the service of process provides the court with the same jurisdiction as would personal service. E. g. U.S. v. Farbenfabriken Bayer, A.G., 157 U.S.P.Q. 674, 1968 CCH Trade Cases ¶ 72,569 (1968). The question, on which this appeal turns, is whether or not this case, involving the patent misuse and antitrust claims alleged here, is a “proceeding affecting the patent or rights thereunder ... ”.

Section 293 was enacted in 1952 as part of a comprehensive revision of the patent law.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

TomTom, Inc. v. AOT Systems GmbH
893 F. Supp. 2d 785 (E.D. Virginia, 2012)
Mama Cares Foundation v. Nutriset Société Par Actions Cimplifiée
825 F. Supp. 2d 178 (District of Columbia, 2011)
Gianelli v. Chirkes
377 F. Supp. 2d 49 (District of Columbia, 2005)
Purdue Research Foundation v. Sanofi-Synthelabo, S.A.
332 F. Supp. 2d 63 (District of Columbia, 2004)
Alaska Legislative Council v. Babbitt
15 F. Supp. 2d 19 (District of Columbia, 1998)
CSU Holdings, Inc. v. Xerox Corp.
964 F. Supp. 1479 (D. Kansas, 1997)
In Re Independent Serv. Organ. Antitrust Lit.
964 F. Supp. 1479 (D. Kansas, 1997)
Anand Prakash v. American University
727 F.2d 1174 (D.C. Circuit, 1984)
United States v. Telectronics Proprietary, Ltd.
607 F. Supp. 753 (D. Colorado, 1983)
Schachel v. Closet Concepts, Inc.
405 So. 2d 487 (District Court of Appeal of Florida, 1981)
Leesona Corporation v. Varta Batteries, Inc.
522 F. Supp. 1304 (S.D. New York, 1981)

Cite This Page — Counsel Stack

Bluebook (online)
636 F.2d 772, 205 U.S. App. D.C. 64, 1980 U.S. App. LEXIS 11944, Counsel Stack Legal Research, https://law.counselstack.com/opinion/riker-laboratories-inc-a-corporation-of-delaware-v-gist-brocades-n-v-cadc-1980.